Diagnostic Histopathology
Volume 15, Issue 2 , Pages 95-98 , February 2009

Pancreatic endocrine neoplasia: familial syndromes

References 

  1. Maioli M, Ciccarese M, Pacifico A, et al. Familial insulinoma: description of 2 cases. Acta Diabetol. 1992;29:38–40
  2. Trump D, Farren B, Wooding C, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN I). QJM. 1996;89:653–669
  3. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276:404–407
  4. Burgess JR, Greenaway TM, Shepherd JJ. Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med. 1999;243:465–470
  5. Jensen RT. Pancreatic endocrine tumors: recent advances. Ann Oncol. 1999;10:S170–S176
  6. Mullan MH, Gauger PG, Thompson NW. Endocrine tumours of the pancreas: review and recent advances. ANZ J Surg. 2001;71:475–482
  7. La Rosa S, Furlan D, Sessa F, et al. The endocrine pancreas. In:  Lloyd RV editors. Endocrine pathology. Differential diagnosis and molecular advances. New Jersey: Humana Press; 2004;p. 291–328
  8. Guo SS, Sawaicli MP. Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type 1. Mol Endocrinol. 2001;15:1653–1664
  9. Calender A, Vercherat C, Gaudray P, et al. Deregulation of genetic pathways in neuroendocrine tumors. Ann Oncol. 2001;12:S3–S11
  10. Hessman O, Skogseid B, Westin G, et al. Multiple allelic deletions and intratumoral genetic heterogeneity in MEN 1 pancreatic tumors. J Clin Endocrinol Metab. 2001;86:1355–1361
  11. Friedrich CA. Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer. 1999;86:2478–2482
  12. Hough MT, Stephens DH, Johnson CD, et al. Pancreatic lesions in von Hippel-Lindau disease: prevalence clinical significance, and CT findings. AJR Am J Roentgenol. 1994;162:1091–1094
  13. Lubensky IA, Pack S, Ault D, et al. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease. Am J Pathol. 1998;153:223–231
  14. Neumann HPH, Dinkel E, Brambs H, et al. Pancreatic lesions in the von Hippel-Lindau syndrome. Gastroenterology. 1991;101:465–471
  15. Binkovitz LA, Johnson CD, Stephens DH. Islet cell tumors in von Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias. AJR Am J Roentgenol. 1990;155:501–505
  16. Chetty R, Kennedy M, Ezzat S, Asa SL. Pancreatic neuroendocrine pathology in a patient with Von Hippel-Lindau disease: an expanding spectrum of lesions. Endocr Pathol. 2004;15:141–148
  17. Hammel PR, Vilgrain V, Terris B, et al. Pancreatic involvement in von Hippel-Lindau disease. Gastroenterology. 2000;119:1087–1095
  18. Savar A, Cestari DM. Neurofibromatosis type I: genetics and clinical manifestations. Semin Ophthalmol. 2008;23:45–51
  19. Jensen RT, Berna MJ, Bingham DB, Norton JA. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer. 2008;113(Suppl.):1807–1843
  20. Verhoef S, van Diemen-Steenvoorde R, Akkersdijk WL, et al. Malignant pancreatic tumor within the spectrum of tuberous sclerosis complex in childhood. Eur J Pediatr. 1999;158:284–287
  21. Francalanci P, Diomedi-Camassei F, Purifacto C, et al. Malignant pancreatic endocrine tumor in a child with tuberous sclerosis. Am J Surg Pathol. 2003;27:1386–1389
  22. Kim H, Kerr A, Morehouse H. The association between tuberous sclerosis and insulinoma. AJNR Am J Neuroradiol. 1995;16:1543–1544
  23. Eledrisi MS, Stuart CA, Alshanti M. Insulinoma in a patient with tuberous sclerosis: is there an association?. Endocr Pract. 2002;8:109–112

PII: S1756-2317(09)00006-1

doi: 10.1016/j.mpdhp.2009.01.005

Diagnostic Histopathology
Volume 15, Issue 2 , Pages 95-98 , February 2009

Article Tools

* Image Usage & Resolution